News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diagcor To Launch Natera’s Panorama ™ Non-Invasive Prenatal Test In Hong Kong


12/16/2013 9:33:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natera today announced that DiagCor, a manufacturer of in-vitro diagnostic products and service provider of clinical diagnostic tests, has signed an agreement to launch Natera’s Panorama™ non-invasive prenatal screening test (NIPT) in Hong Kong. Panorama uses a simple blood draw from the mother to detect trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), monosomy X (Turner’s syndrome), triploidy (Triploid syndrome) and sex chromosome aneuploidies. The test, launched in the United States, is highly accurate and can be performed from nine weeks onward. In contrast to traditional genetic testing like amniocentesis, Panorama causes no risk to the fetus.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Natera
Diagcor
 
 
Pregnancy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES